questionsmedicales.fr
Troubles mentaux
Troubles de la veille et du sommeil
Dyssomnies
Dyssomnies : Questions médicales fréquentes
Termes MeSH sélectionnés :
Cell-Derived Microparticles
Diagnostic
5
Troubles du sommeil
Polysomnographie
Polysomnographie
Journaux de sommeil
Critères diagnostiques
Qualité du sommeil
Troubles psychiatriques
Anxiété
Médecin généraliste
Spécialiste du sommeil
Symptômes
5
Insomnie
Sommeil non réparateur
Changements d'humeur
Anxiété
Fatigue diurne
Somnolence
Prévention
5
Routine de sommeil
Environnement de sommeil
Traitements
5
Thérapie cognitivo-comportementale
Médicaments
Thérapie cognitivo-comportementale
Qualité du sommeil
Benzodiazépines
Non-benzodiazépines
Hygiène du sommeil
Qualité du sommeil
Traitement personnalisé
Causes sous-jacentes
Complications
5
Santé mentale
Maladies cardiovasculaires
Performance au travail
Accidents
Obésité
Hormones de la faim
Dépression
Troubles du sommeil
Maladies chroniques
Hypertension
Facteurs de risque
5
Stress
Troubles psychiatriques
Âge avancé
Changements physiologiques
Antidépresseurs
Médicaments
Mode de vie sédentaire
Hygiène de sommeil
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dyssomnies : Questions médicales les plus fréquentes",
"headline": "Dyssomnies : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dyssomnies : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-28",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dyssomnies"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles de la veille et du sommeil",
"url": "https://questionsmedicales.fr/mesh/D012893",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de la veille et du sommeil",
"code": {
"@type": "MedicalCode",
"code": "D012893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Privation de sommeil",
"alternateName": "Sleep Deprivation",
"url": "https://questionsmedicales.fr/mesh/D012892",
"about": {
"@type": "MedicalCondition",
"name": "Privation de sommeil",
"code": {
"@type": "MedicalCode",
"code": "D012892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.099"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Troubles du rythme circadien du sommeil",
"alternateName": "Sleep Disorders, Circadian Rhythm",
"url": "https://questionsmedicales.fr/mesh/D020178",
"about": {
"@type": "MedicalCondition",
"name": "Troubles du rythme circadien du sommeil",
"code": {
"@type": "MedicalCode",
"code": "D020178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Troubles du sommeil d'origine intrinsèque",
"alternateName": "Sleep Disorders, Intrinsic",
"url": "https://questionsmedicales.fr/mesh/D020919",
"about": {
"@type": "MedicalCondition",
"name": "Troubles du sommeil d'origine intrinsèque",
"code": {
"@type": "MedicalCode",
"code": "D020919",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Troubles du sommeil par somnolence excessive",
"alternateName": "Disorders of Excessive Somnolence",
"url": "https://questionsmedicales.fr/mesh/D006970",
"about": {
"@type": "MedicalCondition",
"name": "Troubles du sommeil par somnolence excessive",
"code": {
"@type": "MedicalCode",
"code": "D006970",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypersomnie idiopathique",
"alternateName": "Idiopathic Hypersomnia",
"url": "https://questionsmedicales.fr/mesh/D020177",
"about": {
"@type": "MedicalCondition",
"name": "Hypersomnie idiopathique",
"code": {
"@type": "MedicalCode",
"code": "D020177",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Kleine-Levin",
"alternateName": "Kleine-Levin Syndrome",
"url": "https://questionsmedicales.fr/mesh/D017593",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Kleine-Levin",
"code": {
"@type": "MedicalCode",
"code": "D017593",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Narcolepsie",
"alternateName": "Narcolepsy",
"url": "https://questionsmedicales.fr/mesh/D009290",
"about": {
"@type": "MedicalCondition",
"name": "Narcolepsie",
"code": {
"@type": "MedicalCode",
"code": "D009290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cataplexie",
"alternateName": "Cataplexy",
"url": "https://questionsmedicales.fr/mesh/D002385",
"about": {
"@type": "MedicalCondition",
"name": "Cataplexie",
"code": {
"@type": "MedicalCode",
"code": "D002385",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cataplexie",
"alternateName": "Cataplexy",
"url": "https://questionsmedicales.fr/mesh/D002385",
"about": {
"@type": "MedicalCondition",
"name": "Cataplexie",
"code": {
"@type": "MedicalCode",
"code": "D002385",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypersomnie idiopathique",
"alternateName": "Idiopathic Hypersomnia",
"url": "https://questionsmedicales.fr/mesh/D020177",
"about": {
"@type": "MedicalCondition",
"name": "Hypersomnie idiopathique",
"code": {
"@type": "MedicalCode",
"code": "D020177",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Kleine-Levin",
"alternateName": "Kleine-Levin Syndrome",
"url": "https://questionsmedicales.fr/mesh/D017593",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Kleine-Levin",
"code": {
"@type": "MedicalCode",
"code": "D017593",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Narcolepsie",
"alternateName": "Narcolepsy",
"url": "https://questionsmedicales.fr/mesh/D009290",
"about": {
"@type": "MedicalCondition",
"name": "Narcolepsie",
"code": {
"@type": "MedicalCode",
"code": "D009290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cataplexie",
"alternateName": "Cataplexy",
"url": "https://questionsmedicales.fr/mesh/D002385",
"about": {
"@type": "MedicalCondition",
"name": "Cataplexie",
"code": {
"@type": "MedicalCode",
"code": "D002385",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cataplexie",
"alternateName": "Cataplexy",
"url": "https://questionsmedicales.fr/mesh/D002385",
"about": {
"@type": "MedicalCondition",
"name": "Cataplexie",
"code": {
"@type": "MedicalCode",
"code": "D002385",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.200.750.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Troubles de l'endormissement et du maintien du sommeil",
"alternateName": "Sleep Initiation and Maintenance Disorders",
"url": "https://questionsmedicales.fr/mesh/D007319",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de l'endormissement et du maintien du sommeil",
"code": {
"@type": "MedicalCode",
"code": "D007319",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.870.400.800.800"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dyssomnies",
"alternateName": "Dyssomnias",
"code": {
"@type": "MedicalCode",
"code": "D020920",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Omar Laraqui",
"url": "https://questionsmedicales.fr/author/Omar%20Laraqui",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire de psychologie, Cognition, Santé, Socialisation, Reims, France."
}
},
{
"@type": "Person",
"name": "Christine Roland-Levy",
"url": "https://questionsmedicales.fr/author/Christine%20Roland-Levy",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire de psychologie, Cognition, Santé, Socialisation, Reims, France."
}
},
{
"@type": "Person",
"name": "Nadia Manar",
"url": "https://questionsmedicales.fr/author/Nadia%20Manar",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Health Engineering, Casablanca, Morocco."
}
},
{
"@type": "Person",
"name": "Salwa Laraqui",
"url": "https://questionsmedicales.fr/author/Salwa%20Laraqui",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Health Engineering, Casablanca, Morocco."
}
},
{
"@type": "Person",
"name": "Tarik Ghailan",
"url": "https://questionsmedicales.fr/author/Tarik%20Ghailan",
"affiliation": {
"@type": "Organization",
"name": "Moroccan Society of Maritime Health, Tangier, Morocco."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Platelet-Derived Microparticles and Autoimmune Diseases.",
"datePublished": "2023-06-17",
"url": "https://questionsmedicales.fr/article/37373420",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241210275"
}
},
{
"@type": "ScholarlyArticle",
"name": "Red Blood Cell-Derived Microparticles Exert No Cancer Promoting Effects on Colorectal Cancer Cells In Vitro.",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/36012587",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23169323"
}
},
{
"@type": "ScholarlyArticle",
"name": "Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36732759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12951-023-01792-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hydrophobicity-Adaptive Polymers Trigger Fission of Tumor-Cell-Derived Microparticles for Enhanced Anticancer Drug Delivery.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37755231",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/adma.202211980"
}
},
{
"@type": "ScholarlyArticle",
"name": "Urinary red blood cell-derived microparticles and phosphatidylserine-exposing red blood cells in glomerular and non-glomerular hematuria patients.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35703591",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cyto.b.22083"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles de la veille et du sommeil",
"item": "https://questionsmedicales.fr/mesh/D012893"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dyssomnies",
"item": "https://questionsmedicales.fr/mesh/D020920"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dyssomnies - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dyssomnies",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dyssomnies",
"description": "Comment diagnostique-t-on une dyssomnie ?\nQuels tests sont utilisés pour évaluer le sommeil ?\nQuels critères sont utilisés pour le diagnostic ?\nLes dyssomnies sont-elles liées à d'autres troubles ?\nQui peut diagnostiquer une dyssomnie ?",
"url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Cell-Derived+Microparticles#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dyssomnies",
"description": "Quels sont les symptômes courants des dyssomnies ?\nComment l'insomnie se manifeste-t-elle ?\nQu'est-ce que l'hypersomnie ?\nLes dyssomnies affectent-elles l'humeur ?\nQuels signes indiquent une fatigue diurne ?",
"url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Cell-Derived+Microparticles#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dyssomnies",
"description": "Comment prévenir les dyssomnies ?\nL'exercice aide-t-il à prévenir les troubles du sommeil ?\nQuels aliments éviter avant de dormir ?\nLe stress influence-t-il le sommeil ?\nLes siestes sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Cell-Derived+Microparticles#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dyssomnies",
"description": "Quels traitements sont disponibles pour les dyssomnies ?\nComment la thérapie cognitivo-comportementale aide-t-elle ?\nQuels médicaments sont utilisés pour traiter l'insomnie ?\nL'hygiène du sommeil est-elle efficace ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Cell-Derived+Microparticles#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dyssomnies",
"description": "Quelles sont les complications des dyssomnies ?\nLes dyssomnies peuvent-elles affecter la performance au travail ?\nY a-t-il un lien entre dyssomnies et obésité ?\nLes dyssomnies augmentent-elles le risque de dépression ?\nComment les dyssomnies affectent-elles la santé physique ?",
"url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Cell-Derived+Microparticles#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dyssomnies",
"description": "Quels sont les facteurs de risque des dyssomnies ?\nL'âge influence-t-il les dyssomnies ?\nLes médicaments peuvent-ils causer des dyssomnies ?\nLe mode de vie influence-t-il le sommeil ?\nLes troubles de santé augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Cell-Derived+Microparticles#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une dyssomnie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique du sommeil, des questionnaires et parfois des études du sommeil."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le sommeil ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La polysomnographie et les journaux de sommeil sont couramment utilisés pour évaluer les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la durée du sommeil, la qualité et l'impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Les dyssomnies sont-elles liées à d'autres troubles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être associées à des troubles psychiatriques ou médicaux comme l'anxiété."
}
},
{
"@type": "Question",
"name": "Qui peut diagnostiquer une dyssomnie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un médecin généraliste ou un spécialiste du sommeil peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des dyssomnies ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'insomnie, l'hypersomnie, la fatigue diurne et des troubles de concentration."
}
},
{
"@type": "Question",
"name": "Comment l'insomnie se manifeste-t-elle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insomnie se manifeste par des difficultés à s'endormir, des réveils fréquents ou un sommeil non réparateur."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hypersomnie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypersomnie est un besoin excessif de sommeil, même après une nuit de sommeil prolongée."
}
},
{
"@type": "Question",
"name": "Les dyssomnies affectent-elles l'humeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des changements d'humeur, de l'irritabilité et de l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une fatigue diurne ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue diurne se manifeste par une somnolence excessive, des difficultés de concentration et une baisse de performance."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dyssomnies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une routine de sommeil régulière, éviter les stimulants et créer un environnement propice au sommeil."
}
},
{
"@type": "Question",
"name": "L'exercice aide-t-il à prévenir les troubles du sommeil ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la qualité du sommeil et réduire le stress."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter avant de dormir ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez la caféine, l'alcool et les repas lourds avant de dormir pour favoriser un meilleur sommeil."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le sommeil ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les dyssomnies, rendant la gestion du stress essentielle."
}
},
{
"@type": "Question",
"name": "Les siestes sont-elles bénéfiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des siestes courtes peuvent être bénéfiques, mais des siestes longues peuvent perturber le sommeil nocturne."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dyssomnies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie cognitivo-comportementale, les médicaments et l'hygiène du sommeil."
}
},
{
"@type": "Question",
"name": "Comment la thérapie cognitivo-comportementale aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à modifier les pensées et comportements liés au sommeil, améliorant ainsi la qualité du sommeil."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter l'insomnie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les benzodiazépines et les non-benzodiazépines sont souvent prescrites pour traiter l'insomnie."
}
},
{
"@type": "Question",
"name": "L'hygiène du sommeil est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de sommeil saines peuvent améliorer la qualité du sommeil et réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels et des causes sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des dyssomnies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de santé mentale, des maladies cardiovasculaires et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Les dyssomnies peuvent-elles affecter la performance au travail ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner une baisse de concentration, de productivité et des accidents au travail."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre dyssomnies et obésité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du sommeil peuvent contribuer à l'obésité en perturbant les hormones de la faim."
}
},
{
"@type": "Question",
"name": "Les dyssomnies augmentent-elles le risque de dépression ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un lien fort entre les troubles du sommeil et le développement de la dépression."
}
},
{
"@type": "Question",
"name": "Comment les dyssomnies affectent-elles la santé physique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent augmenter le risque de maladies chroniques, d'hypertension et de diabète."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des dyssomnies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress, les troubles psychiatriques, l'âge avancé et les habitudes de sommeil irrégulières."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les dyssomnies ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de souffrir de dyssomnies en raison de changements physiologiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils causer des dyssomnies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les antidépresseurs, peuvent perturber le sommeil."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le sommeil ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise hygiène de sommeil augmentent le risque de dyssomnies."
}
},
{
"@type": "Question",
"name": "Les troubles de santé augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme l'apnée du sommeil et l'anxiété augmentent le risque de dyssomnies."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/04/2025
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Laboratoire de psychologie, Cognition, Santé, Socialisation, Reims, France.
University Institute of Occupational Health and Environmental Medicine, Reims, France.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Laboratoire de psychologie, Cognition, Santé, Socialisation, Reims, France.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Graduate School of Health Engineering, Casablanca, Morocco.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Graduate School of Health Engineering, Casablanca, Morocco.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Moroccan Society of Maritime Health, Tangier, Morocco.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
University Institute of Occupational Health and Environmental Medicine, Reims, France.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Graduate School of Health Engineering, Casablanca, Morocco. chlaraqui51@gmail.com.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China. Electronic address: lm99@zju.edu.cn.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Zhengzhou University People's Hospital, Zhengzhou, Henan 450003, P.R. China.
Department of Neurology, The First Affiliated Hospital of Henan University, Kaifeng, Henan 47500, P.R. China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Zhengzhou University People's Hospital, Zhengzhou, Henan 450003, P.R. China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Zhengzhou University People's Hospital, Zhengzhou, Henan 450003, P.R. China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Zhengzhou University People's Hospital, Zhengzhou, Henan 450003, P.R. China.
Publications dans "Dyssomnies" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Zhengzhou University People's Hospital, Zhengzhou, Henan 450003, P.R. China.
Publications dans "Dyssomnies" :
Extracellular microparticles provide a means of cell-to-cell communication and can promote information exchanges between adjacent or distant cells. Platelets are cell fragments that are derived from m...
The biomedical consequences of allogeneic blood transfusions and the possible pathomechanisms of transfusion-related morbidity and mortality are still not entirely understood. In retrospective studies...
Cancer stem cells (CSCs) are crucial for the growth, metastasis, drug resistance, recurrence, and spread of tumors. Napabucasin (NAP) could effectively inhibit CSC, but its mechanism has not been full...
The study discovered a new mechanism for NAP inhibiting tumors. NAP, in addition to inhibiting STAT3, may also inhibit STAT1, thereby inhibiting the expression of CD44, and the stemness of colon cance...
As a combined diagnostic and therapeutic nanoprobe, N...
Tumor-cell-derived microparticles (MPs) can function as anticancer drug-delivery carriers. However, short blood circulation time, large-size-induced insufficient tumor accumulation and penetration int...
Distinguishing glomerular hematuria (GH) from non-glomerular hematuria (NGH) is important for treating the cause of hematuria. We aimed to determine red blood cell-derived microparticles (RMPs) and ph...
All patients received a physical assessment and urological examination. Dysmorphic RBCs (dRBCs) and acanthocytes were examined using a light microscope. The urinary RMPs and PS-exposing RBCs were dete...
The ratio of RMPs to RBCs was higher in GH patients (n = 29) than in NGH patients (n = 29) (1.06 vs. 0.18). The value of the sum of the PS-exposing RBCs plus RMPs divided by the number of RBCs was hig...
Patients with GH have higher numbers of urinary RMPs and PS-exposing RBCs. These parameters have the potential to be predictive tools for classifying GH in the future....
Metastasis is the main cause of death in patients with colorectal cancer (CRC). Apart from platelets, platelet-derived microparticles (PMPs) are also considered important factors that can modify the a...
We used various CRC cell lines, including the epithelial-like HT29 and the mesenchymal-like SW480 and SW620. Confocal imaging was applied to study PMP incorporation into CRC cells. The presence of sur...
We found that CRC cells could incorporate PMPs in a time-dependent manner. Moreover, PMPs could transfer platelet-specific integrins and stimulate the expression of integrins already present on tested...
We conclude that PMPs can fuse into both epithelial-like and mesenchymal-like CRC cells and increase their invasive potential by inducing the expression and release of MMP-2 and MMP-9 via the p38MAPK ...
Studies on microparticles (MPs) in patients with antiphospholipid antibodies (aPL) are sparse and inconclusive. The relation between MPs and different aPL antibody profiles has never been tested. We e...
Megamix (Biocytex) was used to set up the MPs gating according to the datasheet. Markers of Platelet Microparticles (PMPs) were CD41a-PE and annexin-V-FITC that was used to determine phosphatidylserin...
The number of total MPs and EMPs was significantly higher in triple positive groups with respect to single positive group and showed a significant correlation with IgG aβ2GPI titers. The number PMPs w...
Elevated levels of total MPs and EMPs suggest a state of vascular activation in IgG aβ2GPI positive individuals according to the number of positive tests. PMPs may be fast cleared from circulation in ...
Triple-negative breast cancer (TNBC) is a highly heterogeneous tumor characterized by high recurrence and metastasis, with a very poor prognosis, and there are still great challenges in its clinical t...
It is well established that inflammation and platelets promote multiple processes of cancer malignancy. Recently, platelets have received attention for their role in carcinogenesis through the product...
CLL cell lines were co-incubated with different concentrations of human PMPs, and their impact on cell proliferation, mitochondrial DNA copy number, OCR level, ATP production, and ROS content was eval...
The data demonstrated the potency of PMPs in inducing tumoral growth and invasiveness in CLLs through mitochondrial internalization and OXPHOS stimulation which was in line with metabolic shift report...
Altogether, these findings depict a new platelet-mediated pathway of cancer pathogenesis. We also highlight the impact of PMPs in CLL metabolic reprogramming and disease progression....
Immune checkpoint blockade (ICB) therapy, particularly antibodies targeting the programmed death receptor 1 (PD-1) and its ligand (PD-L1), has revolutionized cancer treatment. However, its efficacy as...